Updates

** Shares of generic drugmaker Viatris VTRS.O rise 2.2% to $8.9

** VTRS posts Q2 adj. profit of 62 cents per share compared with analysts' estimate of 56 cents - data compiled by LSEG

** Its quarterly revenue came in at $3.58 billion vs estimates of $3.47 billion

** Company reaffirms its 2025 revenue forecast to be between $13.5 billion and $14 billion

** Also reaffirms its annual adj. profit per share to be between $2.16 and $2.30

** J.P.Morgan says "we see continued core portfolio execution and capital deployment as key drivers of the stock from here"

** Including session moves, stock down 27.8% YTD

(Reporting by Siddhi Mahatole)

((siddhi.mahatole@thomsonreuters.com))